Harkawal Hundal, MD
Interventional Cardiology · Portland, ORNPI 1598994709
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Teleflex LLC at 49.0% of the total. 2025 is the largest year on record at $685, more than ten times the $41 reported in 2020. That places this record below the midpoint for interventional cardiology clinicians in OR, where the typical reported total is $4,729.
Across 30 payments — averaging $43.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$639
- Shockwave Medical, Inc$276
- Philips North America LLC$199
- Abiomed$110
- Asahi Intecc USA, Inc.$41
- Abbott$21
- plus $18 from 1 others
What the payments were for
- Food & beverage$1,304100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 5 | $639 |
| Shockwave Medical, Inc | 10 | $276 |
| Philips North America LLC | 10 | $199 |
| Abiomed | 2 | $110 |
| Asahi Intecc USA, Inc. | 1 | $41 |
| Abbott | 1 | $21 |
| Medtronic | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MANTA$383
How this compares
$1,304 in reported general payments places this provider in the 25th percentile of 68 interventional cardiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 41 | $1,118 |
| Atorvastatin Calcium | 73 | $1,002 |
| Metoprolol Succinate | 71 | $941 |
| Losartan Potassium | 47 | $619 |
| Furosemide | 37 | $522 |
| ClopidogrelClopidogrel Bisulfate | 28 | $497 |
| Carvedilol | 32 | $490 |
| Metoprolol Tartrate | 32 | $381 |
| Spironolactone | 31 | $292 |
| Amlodipine Besylate | 17 | $205 |
| Rosuvastatin Calcium | 16 | $180 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Portland
- Jason WollmuthPortland$749K
- Ethan KorngoldPortland$407K
- Amish DesaiPortland$186K
- Harsh GolwalaPortland$105K
- Brandon JonesPortland$101K
- Kathryn DawsonPortland$57K
- Logan VincentPortland$42K
- Amged AbdelazizPortland$38K
- Richard SohnPortland$38K
- Daniel FeldmanPortland$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.